Abstract: Methods and systems for planarization of a die-to-wafer integration. A planarization coating may be applied to the die-to-wafer assembly, and a planarization plate may be used in the planarization process. The planarization plate may include perforations configured to allow a portion of the planarization coating to extrude through the planarization plate.

Abstract: A processor including a virtualization system of the processor with a memory virtualization support system to map a reference to guest-physical memory made by guest software executable on a virtual machine which in turn is executable on a host machine in which the processor is operable to a reference to host-physical memory of the host machine.

Abstract: A punch assembly is provided in a form, fill, and seal machine that provides a package that includes a sealed end portion and contains an article. The punch assembly includes a housing, and a heat sink provided in and retained by the housing, where the heat sink includes a punch tip that is to provide an opening in the sealed end portion of the package. The punch assembly also includes a coil heater contacting the heat sink to provide heat to the heat sink and the punch tip, where one or more air gaps are provided between the housing and the heat sink to prevent heat transfer from the heat sink to a seal jaw assembly of the form, fill, and seal machine.

Abstract: A processor including a virtualization system of the processor with a memory virtualization support system to map a reference to guest-physical memory made by guest software executable on a virtual machine which in turn is executable on a host machine in which the processor is operable to a reference to host-physical memory of the host machine.

Abstract: The present invention is directed to an ophthalmic peri-corneal drug delivery device. The device includes a core of matrix material and therapeutic agent and a coating over the core. One or more opening[s] extend through the coating to provide for release of the drug to the eye. Moreover, the device is designed to lay atop the external surface of the eye.

Abstract: Systems and methods for vertically integrating semiconductor devices are described. In one embodiment, a method comprises providing an interposer, aligning and bonding a plurality of die to a first surface of the interposer, aligning and bonding a backplate to the plurality of die, and reducing at least one portion of the interposer to create a reconstituted wafer. In another embodiment, an apparatus comprises an interposer operable to receive at least one donor semiconductor device disposed on a first surface of the interposer and aligned therewith, and at least one host semiconductor device disposed on a second surface of the interposer and aligned therewith; where the interposer allows the at least one donor and host semiconductor devices to become vertically integrated.

Abstract: The present invention concerns implantable ocular devices for the sustained release of medication to the eye, and methods for manufacturing and using such devices. In one embodiment, the present invention provides a device comprising: (a) a body comprising a matrix of a prostaglandin and a silicone; (b) a parylene coating on the outer surface of the body; and (c) one or more pores extending from the outer surface of the parylene coating to the outer surface of the body.

Abstract: The present invention provides immunogenic and pharmaceutical compositions for the treatment and prevention of human papillomavirus (HPV)-associated cancers and in particular, cervical cancer. In particular, this invention relates to fusion proteins, and the nucleic acids encoding these fusion proteins, used to generate immune responses against HPV. Specifically, this invention provides for fusions of HPV E6 and E7 in which the E6 and/or E7 contains one or more mutations. These mutations abrogate the transformation activity of these oncogenic proteins and, thus, confer safety to the E6/E7 fusions. In addition, these fusions maintain or increase the immunogenic efficacy of E6 and E7. Any gene or protein delivery method can be used to deliver or package the immunogenic compositions of the present invention.

Abstract: An equine gastric ulcer therapy composition comprises a pre-packaged, dry feed supplement comprising effective amounts of chamomile tea and an effective amount of slippery elm with effective amounts of apples and a natural sweetener. An alternative composition comprises a pour-able aqueous solution of an effective amount of chamomile tea and an effective amount of slippery elm, wherein the solution has a viscosity of at least 100 cP at about 20° C., or about 80 cSt at about 25° C. A method of treating equine ulcers comprises a regime of Omeprazole for an initial treatment period followed by treatment with the described nutraceutical equine gastric ulcer therapy composition.

Abstract: Methods and systems are provided to control the execution of a virtual machine (VM). A VM Monitor (VMM) accesses VM Control Structures (VMCS) indirectly through access instructions passed to a processor. In one embodiment, the access instructions include VMCS component identifiers used by the processor to determine the appropriate storage location for the VMCS components. The processor identifies the appropriate storage location for the VMCS component within the processor storage or within memory.

Abstract: Disclosed are embodiments of methods, systems, and apparatus for providing multiple image fields or regions on an imaging array. In certain preferred embodiments, a high density imaging array may be partitioned into two or more regions, each of which may be used to render a separate view of the scan volume. This arrangement may provide an increase in the effective scan volume beyond the volume available with a single imager having a single point of view and may allow for reading of encoded symbols at a variety of orientations that would otherwise preclude accurate imaging with a single imager.

Abstract: The present invention provides immunogenic and pharmaceutical compositions for the treatment and prevention of human papillomavirus (HPV)-associated cancers and in particular, cervical cancer. In particular, this invention relates to fusion proteins, and the nucleic acids encoding these fusion proteins, used to generate immune responses against HPV. Specifically, this invention provides for fusions of HPV E6 and E7 in which the E6 and/or E7 contains one or more mutations. These mutations abrogate the transformation activity of these oncogenic proteins and, thus, confer safety to the E6/E7 fusions. In addition, these fusions maintain or increase the immunogenic efficacy of E6 and E7. Any gene or protein delivery method can be used to deliver or package the immunogenic compositions of the present invention.

Abstract: An intravenous catheter anchoring assembly is disclosed and includes a patient-contacting membrane, a platform, and a retaining strap for securing a catheter or tubing of an administration set to a patient. The strap is attached to the platform with adjustable pull-tabs that permit a variety of catheter shapes and sizes to be secured. The strap is also elastomeric so that the strap is stretchable and thereby grabs the secured catheter. The strap and platform further define a plurality of passageways that permit the catheter to be secured in a plurality of non-aligned directions.

Abstract: An improved injection site (12) for infusion of parenteral fluids and the like is provided, having a pressure-actuated valve (20) and a novel split septum unit (24), which effectively prevent reflux of blood into the assembly (10). The septum unit (24) includes a resilient split septum body (64) which is precompressed so that the septum body (64) is caused to protrude proximally (78) upon insertion of a cannula (16). Consequently, upon removal of the cannula (16), there is essentially no “drumming” or creation of friction-induced negative pressures sufficient to generate blood reflux. The preloaded septum body (64) also has its proximal surface (74) essentially flush and coplanar with the adjacent proximal end (66b) of the tubular septum holder (66) to enhance the cleanliness of the unit (24).

Abstract: An intravenous catheter anchoring assembly is disclosed and includes a patient-contacting membrane, a platform, and a retaining strap for securing a catheter or tubing of an administration set to a patient. The strap is attached to the platform with adjustable pull-tabs that permit a variety of catheter shapes and sizes to be secured. The strap is also elastomeric so that the strap is stretchable and thereby grabs the secured catheter. The strap and platform further define a plurality of passageways that permit the catheter to be secured in a plurality of non-aligned directions.

Abstract: The present invention provides immunogenic and pharmaceutical compositions for the treatment and prevention of human papillomavirus (HPV)-associated cancers and in particular, cervical cancer. In particular, this invention relates to fusion proteins, and the nucleic acids encoding these fusion proteins, used to generate immune responses against HPV. Specifically, this invention provides for fusions of HPV E6 and E7 in which the E6 and/or E7 contains one or more mutations. These mutations abrogate the transformation activity of these oncogenic proteins and, thus, confer safety to the E6/E7 fusions. In addition, these fusions maintain or increase the immunogenic efficacy of E6 and E7. Any gene or protein delivery method can be used to deliver or package the immunogenic compositions of the present invention.

Abstract: A processor, capable of operation in a host machine, including memory management logic to support a plurality of memory types for a physical memory access by the processor, and virtualization support logic to determine a host memory type for a reference to a memory location by a guest in a virtual machine executable on the processor based at least in part on a memory type field stored in an entry of an extended paging table of a virtualization support system of the host machine (extended memory type field), to determine a guest memory type for the reference to the memory location, and to determine an effective memory type based on at least one of the host memory type and the guest memory type.

Abstract: Method, apparatus, and system for a programmable event driven yield mechanism that may activate other threads. The yield mechanism may allow triggering of a service thread that may execute currently with a main thread upon occurrence of an architecturally-defined condition. The service thread may be activated, in response to the condition, with limited intervention of an operating system. In one embodiment, an apparatus includes execution resources to execute a plurality of instructions and a monitor to detect an architecturally-defined condition. The apparatus may include an event handler to handle a yield event generated when the architecturally-defined condition has been detected. An architectural mechanism, including processor instructions and channel registers, may be utilized to allow user-level code to enable the yield event mechanism. Other embodiments are also described and claimed.

Abstract: Systems and methods for optical scanning, in one configuration, including a torsional dither mechanism having a torsion rod formed of integral construction machined from a single metal piece, magnet and mirror mount attached to the free end of the torsion rod, and electromagnetic drive. The drive comprises a magnet mounted to the magnet mount and a drive coil. Torque is generated on the dither arm as oscillating current is applied to the coil, to preferably drive the torsion rod at a high oscillation speed on the order of 5 KHz. Acoustic noise control is provided by using a combination of elastomeric isolation mounts, a thick wall enclosure and lid for the dither, an electrically resonant dither drive, and mechanically resonant drive control using back EMF from a moving magnet to set the frequency of oscillation of the dither drive.